SANDOSTATIN LAR

Google image searchProduct monograph

Active ingredient

octreotide (octreotide acetate), 30 MG/VIAL

DIN: 02239325

Dosage form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE

Route(s) of administration: INTRAMUSCULAR

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 27-JAN-1999

ATC:

• H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
• H01C — HYPOTHALAMIC HORMONES (ATC, ATC/DDD)
• H01CB — Antigrowth hormones (ATC, ATC/DDD)
• H01CB02 — OCTREOTIDE (ATC/DDD)

Reference brand drug: Sandostatin

Pharmaceutical standard: MFR

External Links for Sandostatin Lar

Search on Google

• Sandostatin Lar side effects
• Sandostatin Lar dosage
• octreotide side effects
• octreotide dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find sandostatin lar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.